- 询价
- abinScience
- China
- VK415203
- 2026年03月03日
- ELISA, FCM, WB
- Human
- Vaccinia
企业认证
相关产品推荐更多 >
Anti-PIIICP/COL3A1 Polyclonal Antibody, 抗PIIICP/COL3A1多克隆抗体
￥1008
Anti-Human SYNGAP1 Polyclonal Antibody 一 抗, 抗Human SYNGAP1 Polyclonal Antibody 一 抗
￥1668
Anti-Alpha-toxin/hly/AT Antibody (QD20), 抗Alpha-toxin/hly/AT抗体 (QD20)
￥1338
Anti-Coxiella burnetii CBU_1869 Polyclonal Antibody, 抗Coxiella burnetii CBU_1869 多克隆抗体
￥1008
InVivo Plus Human IgD kappa Isotype Control Antibody (HyHEL-10)
询价
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
源叶生物 十万种现货试剂速发，品质稳、品类全，实验不再等！Takara 秋促来袭，提取+反转录+定量套装仅 1200 元abinScience 体内级抗体 全年锁价 低至 ￥1200阿拉丁 22万+ 科研级产品现货速发，品质严控、科研无忧- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
/
- 亚型：
IgA, kappa
- 形态：
Liquid
- 保存条件：
0.01M PBS pH 7.4
- 克隆性：
Monoclonal
- 标记物：
Unconjugated
- 适应物种：
Vaccinia
- 保质期：
1 year
- 抗原来源：
Human
- 目录编号：
VK415203
- 级别：
科研级别
- 库存：
999
- 供应商：
abinScience
- 宿主：
Human
- 应用范围：
ELISA, FCM, WB
- 浓度：
/
- 靶点：
OPG154, Protein OPG154, A27
- 抗体英文名：
Anti-Vaccinia A27 IgA Antibody (SAA2663)
- 抗体名：
Anti-Vaccinia A27 IgA Antibody (SAA2663)
- 规格：
50ug/100ug/1mg
| Product name | Anti-Vaccinia A27 IgA Antibody (SAA2663) |
|---|---|
| Catalog No. | VK415203 |
| Host species | Human |
| Species reactivity | Vaccinia |
| Immunogen | / |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4 |
| Concentration | / |
| Purity | >95% as determined by SDS-PAGE. |
| Clonality | Monoclonal |
| Isotype | IgA, kappa |
| Applications | ELISA, FCM, WB |
| Target | OPG154, Protein OPG154, A27 |
| References | / |
| Purification | Protein A/G purified from cell culture supernatant. |
| Biological activity | / |
| Endotoxin level | <10 EU/mg |
| Expression system | / |
| Accession | P11258 |
| Label | / |
| Protein length | / |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Reconstitution | / |
| Detection method | / |
| Alternative Names | / |
| Clone ID | SAA2663 |
| Note | For research use only |
abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.
Technology and Innovation
Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for abinScience's product research and development.
Product categories and application fields.
Main products.
10000+ high-activity proteins.
15000+ antibody series products:
Classic monoclonal antibody.
Monoclonal antibody
Internal control antibody, labeled antibody.
High-quality phosphorylation antibodies.
Highly specific nanobodies and small molecule antibodies.
Functional antibodies in vivo.
Low-background flow cytometry antibodies.
DNA/RNA antibodies and PEG antibodies.
1000+ reagent kit series products.
Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.
Application field
Infectious disease research: including viruses, superbugs, parasites, etc.
Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
Oncology research: Supporting the development of tumor biology and anti-tumor drugs.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验作者：陈英剑 李芳秋 摘要 以ｒｈＣｙＰＡ为包被抗原，用间接ＥＬＩＳＡ检测了４５例ＳＬＥ病人血浆抗ＣｙＰＡ自身抗体的ＩｇＧ、ＩｇＡ、ＩｇＭ三种类型，并探讨了此抗体与多项临床指标的相关性。结果显示，ＩｇＧ、ＩｇＡ、ＩｇＭ三类抗ＣｙＰＡ自身抗体的阳性率分别为３６％，２０％，１８％，总阳性率为４８％。存在皮肤粘膜损害、白细胞减少、发热、并联能表现或活动期的ＳＬＥ病人抗ＣｙＰＡ自身抗体阳性率明显高于无相应症状或非活动期ＳＬＥ病人。 An investigation
会在产品说明书中都会有描述，如果你的一抗是小鼠IgM，那么相应的二抗就应当是抗小鼠IgM。如果单克隆一抗是小鼠IgG的某一亚类（IgG1，IgG2a，IgG2b，IgG3），那么几乎所有的抗小鼠IgG都可以与之结合，或者你也可以选择专门针对这一亚类的二抗，例如，如果你的一抗是小鼠IgG1，那么你可以选择抗IgG1的二抗，此种抗体在双标记实验中尤其适合。在不清楚一抗为何种类/亚类的情况下，可以选用抗相应物种IgG。***捷能为您提供通用的IgG（H+L）二抗，或者特异性只结合IgM的Anti IgM
。如果单克隆一抗是小鼠IgG的某一亚类（IgG1，IgG2a，IgG2b，IgG3），那么几乎所有的抗小鼠IgG都可以与之结合，或者你也可以选择专门针对这一亚类的二抗，例如，如果你的一抗是小鼠IgG1，那么你可以选择抗IgG1的二抗，此种抗体在双标记实验中尤其适合。在不清楚一抗为何种类/亚类的情况下，可以选用抗相应物种IgG。艾美捷能为您提供通用的IgG（H+L）二抗，或者特异性只结合IgM的Anti IgM （mu） Antibody、IgA的Anti IgA （alpha-Antibody、IgE
技术资料暂无技术资料 索取技术资料
